Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

PRP is a promising, cost-effective treatment for hair loss by stimulating hair growth.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

The study created a mouse model to mimic degenerative diseases for testing tissue repair and new therapies.

Injecting lentiviral vectors into early gestation mice effectively targets skin stem cells for potential gene therapy.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Blood count parameters are not reliable for predicting recurrent implantation failure.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

The new method is 1000 times more sensitive for measuring hair growth.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

CD200- cells in hair follicles have a higher ability to regenerate hair.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

PRP helps skin regeneration but needs standardized testing for consistent results.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

New biomarkers and potential treatments for skin diseases were identified.

The microneedle device with rapamycin and epigallocatechin gallate effectively promoted hair regrowth in mice.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

A new method allows detailed tracking of cell regeneration in crustacean legs.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.